Pulmonary Fibrosis: About Clinical Trials

Clinical trials are well-designed studies used to collect information about new treatments for diseases and disorders. Most of the time, this means medications, but clinical trials can also test other things, such as stem cell therapies, surgical techniques, tests for diagnosis, medical devices, as well as…

“This simple video presents a basic understanding of idiopathic pulmonary fibrosis (IPF). This fatal condition does not have a known cause and research investigating its pathology is ongoing.” Learn more about Idiopathic Pulmonary Fibrosis: https://bit.ly/1QiRmr3…

Researchers discovered that mechanotherapy on damaged muscle tissue reduces both fibrotic tissue accumulation and inflammation while helping to increase tissue regeneration, according to a new study titled “Biologic-free mechanically induced muscle regeneration,” published in the journal Proceedings of the National Academy of Sciences (PNAS). Although focusing on the repair…

Spherix Global Insights, GmbH, a business intelligence and market research company based in Switzerland, recently reported a study revealing that idiopathic pulmonary fibrosis (IPF) remains a challenge in terms of treatment, especially since the majority of patients are diagnosed at already advanced disease stages. The Spherix…

UT Health Northeast, a medical center that is part of the University of Texas system, recently announced in a press release that four of its scientists have received a total of $2.1 million in competitive research grants. The researchers are Dr. Vijay Rao, Dr. Krishna Vankayalapati, Dr. Hong-Long Ji,…

“Ever wanted to know what NOT to say to someone living with a chronic illness? Well here is your 101 on things you probably shouldn’t say.” Learn more about pulmonary fibrosis: https://bit.ly/1lfMsiZ…

Last week’s hot topic on pulmonary fibrosis was NY Times Covers Story of IPF Patient’s Progress with Esbriet Treatment written by Isaura Santos. This article follows a story covered by the NY Times, about an IPF patient’s…